These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 14522622)
1. An open-label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema. Thelmo MC; Lang W; Brooke E; Osborne BE; McCarty MA; Jorizzo JL; Fleischer A J Dermatolog Treat; 2003 Sep; 14(3):136-40. PubMed ID: 14522622 [TBL] [Abstract][Full Text] [Related]
2. Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study. Katsarou A; Makris M; Papagiannaki K; Lagogianni E; Tagka A; Kalogeromitros D Eur J Dermatol; 2012; 22(2):192-6. PubMed ID: 22407003 [TBL] [Abstract][Full Text] [Related]
3. Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper. Krejci-Manwaring J; McCarty MA; Camacho F; Manuel J; Hartle J; Fleischer A; Feldman SR J Drugs Dermatol; 2008 Jul; 7(7):643-6. PubMed ID: 18664156 [TBL] [Abstract][Full Text] [Related]
4. Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. Schnopp C; Remling R; Möhrenschlager M; Weigl L; Ring J; Abeck D J Am Acad Dermatol; 2002 Jan; 46(1):73-7. PubMed ID: 11756949 [TBL] [Abstract][Full Text] [Related]
5. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study. Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990 [TBL] [Abstract][Full Text] [Related]
7. Development of calcineurin blocking non-steroid topical immunosuppressants for effective management of eczema. Groves R J Dermatolog Treat; 2003 Sep; 14(3):135. PubMed ID: 14522621 [No Abstract] [Full Text] [Related]
8. Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis. Schliemann S; Kelterer D; Bauer A; John SM; Skudlik C; Schindera I; Wehrmann W; Elsner P Contact Dermatitis; 2008 May; 58(5):299-306. PubMed ID: 18416762 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Reitamo S; Wollenberg A; Schöpf E; Perrot JL; Marks R; Ruzicka T; Christophers E; Kapp A; Lahfa M; Rubins A; Jablonska S; Rustin M Arch Dermatol; 2000 Aug; 136(8):999-1006. PubMed ID: 10926735 [TBL] [Abstract][Full Text] [Related]
10. Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study. Braza TJ; DiCarlo JB; Soon SL; McCall CO Br J Dermatol; 2003 Jun; 148(6):1242-4. PubMed ID: 12828755 [TBL] [Abstract][Full Text] [Related]
11. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C; Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994 [TBL] [Abstract][Full Text] [Related]
12. Topical treatment of perianal eczema with tacrolimus 0.1%. Schauber J; Weisenseel P; Ruzicka T Br J Dermatol; 2009 Dec; 161(6):1384-6. PubMed ID: 19575757 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. Reitamo S; Rustin M; Ruzicka T; Cambazard F; Kalimo K; Friedmann PS; Schoepf E; Lahfa M; Diepgen TL; Judodihardjo H; Wollenberg A; Berth-Jones J; Bieber T; J Allergy Clin Immunol; 2002 Mar; 109(3):547-55. PubMed ID: 11898005 [TBL] [Abstract][Full Text] [Related]
14. A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea. Won CH; Seo PG; Park YM; Yang JM; Lee KH; Sung KJ; Park CW; Kim DW; Chang HS; Won YH; Kim KH J Dermatolog Treat; 2004 Jan; 15(1):30-4. PubMed ID: 14754647 [TBL] [Abstract][Full Text] [Related]
16. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL; Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204 [TBL] [Abstract][Full Text] [Related]
17. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial. Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis. Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874 [TBL] [Abstract][Full Text] [Related]
19. Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis. Katsarou A; Armenaka M; Vosynioti V; Lagogianni E; Kalogeromitros D; Katsambas A J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):382-7. PubMed ID: 19207676 [TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K; Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]